Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
•
General Internal Medicine
Is there a role for bromhexine for thick secretions during/after head and neck RT?
How would its use be different from guaifenesin?
Related Questions
Is there a role for prophylactic Trental and vitamin E in a patient at high risk for osteoradionecrosis?
Do you prescribe respiratory muscle training (RMT) devices to patients with dysphagia?
Would you change treatment approach for rectal cancer with an associated intussusception?
Which patients, if any, treated according to PROSPECT for an early stage rectal cancer, would you offer surveillance if they achieved cCR after neoadjuvant chemotherapy?
What is your radiation dose/volume for adjuvant treatment of a clear cell odontogenic carcinoma of the mandible after segmental resection?
How do you treat SNUC?
How would you manage a presumed radiation induced sarcoma of the head and neck?
Has there been an observed interaction between ACE inhibitors and development of angioedema in a block demarcated superficial radiation therapy treatment volume (ex. lip)?
How should you approach treating curable laryngeal cancer with chemo-RT in a patient who had a myocardial infarction during treatment and requires CABG, given the cardiotoxicity of cisplatin and 5FU/carboplatin?
How do you manage persistent rectal bleeding in the setting of rectal adenocarcinoma in a treatment-naive patient?
